AKTX vs YYGH Comparison

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

YY Group Holding Ltd is a data and technology-driven company focused on developing enterprise intelligent labor matching services and smart cleaning services, founded in Singapore. Through its subsidiaries, it provides enterprise manpower outsourcing and smart cleaning services in Singapore, Malaysia, and other countries. The group's reportable segments are Manpower outsourcing services and Cleaning Service. Maximum revenue is generated from the Cleaning Service segment, which is engaged in acting as a contractor to provide long-term cleaning services to hotels and shopping malls, including the areas of toilets, common areas, bin centers, elevators, etc. Geographically, a majority of the group's revenue is generated from its operations in Singapore and Malaysia.